12:00 AM
 | 
Feb 09, 2009
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Abraxis sales and marketing update

Abraxis launched its Abraxane albumin-bound paclitaxel in Germany. The price is not disclosed. The drug is approved in...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >